Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNJ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FNDC3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DRC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CORIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H3F3AP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NECTIN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VLDLR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYLIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on